Evidence map›Paper›PMID 39566468›Full record

ArticleCell reports. Medicine2024

Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response.

Rachel Brandes-Leibovitz, Anca Riza, Gal Yankovitz, Andrei Pirvu, Stefania Dorobantu, Adina Dragos, Ioana Streata, Isis Ricaño-Ponce, Aline de Nooijer, Florentina Dumitrescu and 13 more

Abstract read
In one paragraph

Article in Cell reports. Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. IFNγ in human sepsis: a scoping review.Annals of intensive care · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Rachel Brandes-LeibovitzThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Anca RizaHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Gal YankovitzThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Andrei PirvuHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Stefania DorobantuHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Adina DragosHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Ioana StreataHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Isis Ricaño-PonceIntensive Care Unit, G. Gennimatas Thessaloniki General Hospital, Thessaloniki, Greece.
Aline de NooijerIntensive Care Unit, G. Gennimatas Thessaloniki General Hospital, Thessaloniki, Greece.
Florentina DumitrescuHospital for Infectious Diseases and Pneumology "Victor Babeş" Craiova, Craiova, Romania; Infectious Disease Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Nikolaos Antonakos4(th) Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Eleni AntoniadouIntensive Care Unit, G. Gennimatas Thessaloniki General Hospital, Thessaloniki, Greece.
George Dimopoulos3(rd) Department of Critical Care Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Ioannis KoutsodimitropoulosIntensive Care Unit, Latseion General Hospital, Elefsis, Greece.
Theano Kontopoulou1(st) Department of Internal Medicine, Evangelismos Athens General Hospital, Athens, Greece.
Dimitra MarkopoulouIntensive Care Unit, KAT General Hospital, Kifissia, Athens, Greece.
Eleni AimoniotouIntensive Care Unit, Aghios Dimitrios General Hospital, Thessaloniki, Greece.
Apostolos KomnosIntensive Care Unit, Koutlibaneion and Triantafylleion General Hospital, Larissa, Greece.
George N DalekosDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece.
Mihai IoanaHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Regional Centre of Medical Genetics Dolj, County Clinical Emergency Hospital Craiova, Craiova, Romania.
Evangelos J Giamarellos-Bourboulis4(th) Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece; Hellenic Institute for the Study of Sepsis, Athens, Greece.
Irit Gat-ViksThe Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: iritgv@tauex.tau.ac.il.
Mihai G NeteaHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany. Electronic address: mihai.netea@radboudumc.nl.

Funding

EUROPEAN HORIZON 847422
6 · The paper itself

Abstract

Patients with sepsis differ in their clinical presentations and immune dysregulation in response to infection, but the fundamental processes that determine this heterogeneity remain elusive. Here, we aim to understand which types of immune dysregulation characterize patients with sepsis. To that end, we investigate sepsis pathogenesis in the context of two transcriptional states: one represents the immune response to eliminate pathogens (resistance, R) and the other is associated with systemic inflammation (SI). We find that patients with sepsis share a molecular fingerprint of a low R-to-SI balance-i.e., a low R relative to the level of SI. Differences between patients with sepsis are explained by the wide diversity of R and SI states that fall under this fingerprint, such as patients with high SI, patients with low R, or both. We show how this R/SI framework can be used to guide patient stratification that is relevant to disease prognosis and management, outperforming existing classifications of sepsis.

Indexed as

InflammationSepsisHumansPrognosisTranscription, GeneticTranscriptomeimmune responseimmunotheraphyinfectionpatient stratificationpersonalized medicineprecision medicinesepsisseptic shocksystemic inflammation

Identifiers

PMID39566468
PMCPMC11604535

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.